A new in situ, personalized cancer vaccine captures molecules from growing tumors to activate the body’s immune cells against them.
A non-surgical option for women who suffer from endometriosis, this nanoparticle therapy shows promising preliminary results.
Using nanoparticles fitted with ACE2 receptors, researchers hope to lure SARS-CoV-2 away from healthy cells to inhibit the virus and treat infection.
Researchers have created stiff, recyclable hydrogels that can be broken down into their base components and reshaped on demand.
Hybrid microrobots harvest chemical energy from their environment for self-propulsion while releasing reactive species to kill bacteria.
Synthesized microrobots capable of converting their mechanical motion into a means of self-propulsion.
The strong adhesive nature of this artificial tissue combined with its ability to sustain the growth of new cells helps solve long-standing challenges with these types of grafts.
“Brain-on-a-chip” shows minute-by-minute how the blood–brain barrier reacts to high levels of inflammation.
A well-based microfluidic device allows researchers to generate important data that are needed to better understand the parameters that influence evolution in bacteria to combat antibiotic resistance.
A structurally representative liver-on-a-chip models the full progression of non-alcoholic fatty liver disease, which researchers hope will lead to better treatments.